Clinical Trials Directory

Trials / Completed

CompletedNCT01394159

22G FNA Needle vs. 22G ProCore Needle

Randomized Trial Comparing the 22-gauge Aspiration and 22-gauge Biopsy Needles for EUS-guided Sampling of Solid Pancreatic Mass Lesions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
AdventHealth · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The aim of this research study is to identify the best needle for performing biopsy during EUS procedures. There are two types of needles for performing biopsy: A FNA needle that provides a small sample of tissue for analysis and a 22G ProCore needle that provides larger amount of tissue. It is not clear at this point which of the two needles is superior for performing biopsy. This study will attempt to identify the better needle by assessing the performance of both needles in a randomized fashion.

Detailed description

In this randomized trial, the 22G standard fine needle aspiration needle was compared with the newly developed 22G ProCore needle for sampling pancreatic mass lesions during endoscopic ultrasound. Patients were randomized into the two needle groups and then various outcomes were compared between the two needle types, including the number of passes needed to establish a diagnosis, the ability to procure enough tissue sample to be able to make a diagnosis, the rates of needle failure and complication rates.

Conditions

Interventions

TypeNameDescription
PROCEDURE22G ProCore biopsy needleTissue will be acquired with the 22G Procore biopsy needle and the sample will be compared to the sample obtained with the 22G standard FNA needle.
PROCEDURE22G standard FNA needleTissue will be acquired with the 22G standard FNA biopsy needle and the sample will be compared to the sample obtained with the 22G ProCore biopsy needle.

Timeline

Start date
2011-07-01
Primary completion
2011-09-01
Completion
2011-12-01
First posted
2011-07-14
Last updated
2018-03-09
Results posted
2015-04-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01394159. Inclusion in this directory is not an endorsement.